FDA’s Good Review Management Practices To Debut In “Near Future”
This article was originally published in The Tan Sheet
The long-awaited good review management practice procedure is ready to be rolled out, according to Center for Drug Evaluation and Research Deputy Director Douglas Throckmorton
You may also be interested in...
With the ink of the reauthorized Prescription Drug User Fee Act still drying, FDA is signaling that it may be some time before the agency will consistently meet the performance goals of its user fee program
Drug manufacturers made a pledge to contribute $80 bil. in a mix of savings and revenue-raising initiatives to help fund health reform. In return, they could see a wide range of new business depending on how you look at the numbers.
Despite voting that King's CorVu is not equivalent to its study comparator, Cardio-Renal panel sees bright future for the stress agent.